Study guide
12.4 Immunodeficiency Syndromes, Tumor/Transplant Immunology, and Vaccine Types
NPLEX Part I — Biomedical Sciences Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Pacing, and GEA Strategy
1.1 Overview of NPLEX Part I & NABNE Exam Structure 1.2 Deconstructing Biomedical Clinical Vignettes 1.3 General Exam Areas (GEAs) & Passing Standards
2 Chapter 2: Gross Anatomy & Musculoskeletal System
2.1 Musculoskeletal Anatomy of Upper and Lower Extremities 2.2 Structural Anatomy of Head, Neck, Thorax, and Abdomen 2.3 Pelvic Architecture, Perineal Anatomy, and Articular Structures
3 Chapter 3: Histology & Microscopic Anatomy
3.1 Histology of Epithelial, Connective, and Muscular Tissues 3.2 Microscopic Structure of Gastrointestinal, Renal, and Endocrine Organs 3.3 Microscopic Anatomy of Integument, Lymphoid Tissues, and Respiratory Epithelium
4 Chapter 4: Neuroanatomy & Special Senses
4.1 Cranial Nerves, Nuclei, and Peripheral Distribution 4.2 Spinal Cord Tracts, Brainstem Circuits, and Motor/Sensory Pathways 4.3 Cerebral Cortex, Basal Ganglia, Limbic System, and Autonomic Nervous System 4.4 Neuroanatomy of Vision, Audition, Vestibular Function, and Olfaction/Gustation
5 Chapter 5: Embryology & Developmental Anatomy
5.1 Gametogenesis, Fertilization, Blastulation, and Germ Layer Derivatives 5.2 Organogenesis: Cardiovascular and Respiratory System Development 5.3 Gastrointestinal, Urogenital, and Craniofacial Embryology
6 Chapter 6: Cellular & General Physiology
6.1 Membrane Transport Mechanics, Resting Potentials, and Ion Channels 6.2 Action Potential Propagation and Synaptic Transmission 6.3 Excitation-Contraction Coupling in Skeletal, Cardiac, and Smooth Muscle
7 Chapter 7: Cardiovascular & Respiratory Physiology
7.1 Cardiac Electrophysiology, ECG, and Mechanical Cardiac Cycle 7.2 Hemodynamics, Peripheral Resistance, and Blood Pressure Control 7.3 Pulmonary Mechanics, Lung Volumes, and Gas Exchange Dynamics 7.4 Transport of Oxygen/CO2 and Neural/Chemical Control of Breathing
8 Chapter 8: Renal, Fluid, & Acid-Base Physiology
8.1 Glomerular Filtration Rate and Tubular Reabsorption/Secretion Mechanics 8.2 Countercurrent Multiplication, Osmoregulation, and Urine Concentration 8.3 Body Fluid Compartments, Sodium/Water Homeostasis, and Potassium Dynamics 8.4 Renal & Respiratory Acid-Base Regulation and Compensation Mechanisms
9 Chapter 9: Gastrointestinal, Endocrine, & Reproductive Physiology
9.1 GI Motility, Secretory Functions, Digestion, and Nutrient Absorption 9.2 Hypothalamic-Pituitary Axes, Adrenal Gland, and Thyroid Physiology 9.3 Endocrine Pancreas, Glucose Regulation, Calcium/Phosphate Homeostasis 9.4 Male and Female Reproductive Endocrinology and Menstrual Cycle Regulation
10 Chapter 10: Enzymology, Bioenergetics, & Carbohydrate/Lipid Metabolism
10.1 Enzyme Kinetics, Catalytic Mechanisms, and Vitamin Cofactors 10.2 Glycolysis, Pyruvate Dehydrogenase, TCA Cycle, and Oxidative Phosphorylation 10.3 Glycogen Metabolism, Gluconeogenesis, and Pentose Phosphate Pathway 10.4 Fatty Acid Synthesis, Beta-Oxidation, Ketogenesis, and Lipoprotein Transport
11 Chapter 11: Amino Acid/Nucleotide Metabolism & Clinical Genetics
11.1 Amino Acid Degradation, Transamination, and Urea Cycle Disorders 11.2 Purine and Pyrimidine Synthesis, Salvage, and Gout Pathophysiology 11.3 Mendelian Inheritance, Chromosomal Abnormalities, and Molecular Genetics
12 Chapter 12: Immunology & Immunopathology
12.1 Innate Immune Barriers, Phagocytosis, Cellular Pattern Recognition, and Complement System 12.2 Adaptive Immunity: T-Cell & B-Cell Activation, MHC Restriction, and Antibodies 12.3 Types I-IV Hypersensitivity Reactions and Mechanisms of Autoimmunity 12.4 Immunodeficiency Syndromes, Tumor/Transplant Immunology, and Vaccine Types
13 Chapter 13: Medical Microbiology
13.1 Medical Bacteriology: Gram-Positive, Gram-Negative, and Atypical Bacteria 13.2 Medical Virology: DNA, RNA, Retroviruses, and Viral Pathogenesis 13.3 Medical Mycology: Cutaneous, Systemic, and Opportunistic Fungal Infections 13.4 Medical Parasitology: Protozoan and Helminthic Pathogens
14 Chapter 14: General Pathology & Neoplasia
14.1 Cellular Adaptation, Reversible/Irreversible Injury, Necrosis, and Apoptosis 14.2 Acute and Chronic Inflammation, Chemical Mediators, and Tissue Healing 14.3 Neoplasia: Benign vs Malignant Features, Carcinogenesis, Oncogenes, and Tumor Suppressors
15 Chapter 15: Systems Pathology & Disease Mechanisms
15.1 Pathophysiology of Atherosclerosis, Heart Failure, COPD, and Pneumonias 15.2 Glomerulonephritis, Inflammatory Bowel Disease, and Hepatorenal Disease Pathophysiology 15.3 Endocrine Disorders, Neurodegenerative Pathology, and Epidemiological Principles 15.4 Hematopoietic System Pathology: Anemias, Coagulopathies, and Hematologic Neoplasms 15.5 Immunological System Pathology: Autoimmune, Amyloid, and Systemic Immune-Mediated Disease 15.6 Integumentary System Pathology: Inflammatory Dermatoses, Blistering Disorders, and Skin Neoplasms 15.7 Musculoskeletal System Pathology: Metabolic Bone Disease, Arthropathies, and Bone Neoplasms 15.8 Reproductive System Pathology: Endocrine, Inflammatory, and Neoplastic Disorders of the Reproductive Tract
12.4 Immunodeficiency Syndromes, Tumor/Transplant Immunology, and Vaccine Types
Key Takeaways Explain This Topic AI
Primary immunodeficiencies arise from genetic defects in B cells (Bruton XLA, IgA deficiency), T cells (DiGeorge), combined T/B cells (SCID, Wiskott-Aldrich, Hyper-IgM), or phagocytes (CGD).
Clinical features dictate diagnosis: XLA presents after 6 months with absent B cells; SCID presents in early infancy with absent T/B cells and thrush; DiGeorge presents with 22q11 deletion, hypocalcemia, and thymic aplasia.
Transplant rejection ranges from Hyperacute (minutes, pre-existing antibodies, thrombosis) and Acute (weeks/months, T-cell vasculitis or DSAs) to Chronic (months/years, arteriosclerosis, fibrosis), while GVHD involves donor T cells attacking recipient skin, liver, and GI tract.
Vaccines are categorized into Live Attenuated (MMR, Varicella; strong cell-mediated/humoral, contraindicated in pregnancy/immunodeficiency), Inactivated/Killed (Rabies, Hepatitis A; humoral only), and Subunit/Toxoid (Tetanus, Hib conjugate).
Last updated: July 2026
12.4 Immunodeficiency Syndromes, Tumor/Transplant Immunology, and Vaccine Types
Immunology encompasses disorders of immune deficiency, the immunologic barriers to organ transplantation, and artificial immunization through vaccination.
Primary Immunodeficiency Syndromes (PIDs)
Primary immunodeficiencies are congenital, genetic disorders affecting specific arms of the immune system. +------------------------------------+-----------------------------+------------------------------------+-------------------------------------------+
| Condition | Genetic / Molecular Defect | Laboratory Findings | Clinical Presentation & Key Features |
+------------------------------------+-----------------------------+------------------------------------+-------------------------------------------+
| X-Linked Agammaglobulinemia | BTK gene mutation (Bruton | Absent B cells (CD19/CD20-); | Recurrent sinopulmonary bacterial/entero- |
| (Bruton XLA) | tyrosine kinase) | profoundly low all Ig classes | viral infections after 6 mos; no tonsils |
+------------------------------------+-----------------------------+------------------------------------+-------------------------------------------+
| Selective IgA Deficiency | Failure of IgA B-cell | Low/absent IgA (<7 mg/dL); | Most common PID; mucosal infections; |
| | differentiation | normal IgG and IgM | severe anaphylaxis to IgA blood products |
+------------------------------------+-----------------------------+------------------------------------+-------------------------------------------+
| Severe Combined Immunodeficiency | X-linked IL-2RG defect or | Profound lymphopenia; absent | Failure to thrive, chronic diarrhea, thrush,|
| (SCID) | ADA deficiency | T cells; absent thymic shadow | opportunistic infections; early infant death|
+------------------------------------+-----------------------------+------------------------------------+-------------------------------------------+
| DiGeorge Syndrome | 22q11.2 microdeletion | Decreased T cells; low PTH and | Triad: Thymic aplasia, Hypocalcemia, |
| | (3rd/4th pharyngeal pouch) | serum calcium | Conotruncal heart defects (CATCH-22) |
+------------------------------------+-----------------------------+------------------------------------+-------------------------------------------+
| Wiskott-Aldrich Syndrome | WAS gene X-linked mutation | High IgE/IgA, low IgM; | Triad (WATER): Wiskott-Aldrich, Thrombocy-|
| (WAS) | (actin cytoskeleton defect) | microthrombocytes (small platelets)| topenia (eczema), Recurrent infections |
+------------------------------------+-----------------------------+------------------------------------+-------------------------------------------+
| Hyper-IgM Syndrome | CD40L (CD154) gene defect | Markedly high/normal IgM; | Defective class switching; recurrent |
| | on CD4+ T helper cells | low/absent IgG, IgA, IgE | pyogenic & opportunistic (Pneumocystis) inf|
+------------------------------------+-----------------------------+------------------------------------+-------------------------------------------+
| Chronic Granulomatous Disease | NADPH oxidase subunit defect| Negative NBT dye test; abnormal | Recurrent catalase-positive bacterial/ |
| (CGD) | (gp91phox X-linked) | DHR flow cytometry assay | fungal infections (S. aureus, Aspergillus)|
+------------------------------------+-----------------------------+------------------------------------+-------------------------------------------+
Detailed Primary Immunodeficiency Profiles
X-Linked Agammaglobulinemia (Bruton XLA): Defect in Bruton Tyrosine Kinase (BTK) prevents pre-B cell signal transduction, halting light-chain rearrangement and B-cell maturation. Peripheral blood exhibits complete absence of mature B cells ( C D 19 + , C D 20 − CD19^+, CD20^- C D 1 9 + , C D 2 0 − ) and absent lymphoid tissue (tonsils, lymph node germinal centers). Maternal IgG provides protection for the first 6 months of life; thereafter, infants suffer recurrent pyogenic bacterial sinopulmonary infections ( S. pneumoniae , H. influenzae ) and enteroviral infections (echovirus, poliovirus).
Selective IgA Deficiency: The most common primary immunodeficiency (~1 in 600 individuals). Characterized by severe reduction in serum and mucosal IgA with normal IgG and IgM levels. Many individuals are asymptomatic; others experience recurrent mucosal sinopulmonary infections, GI infections ( Giardia lamblia ), and autoimmune diseases (Celiac disease). CRITICAL PEARL: Patients develop anti-IgA antibodies and risk life-threatening anaphylaxis upon transfusion of blood products containing IgA. They must receive washed red blood cells or IgA-deficient blood.
Severe Combined Immunodeficiency (SCID): Defect in both cell-mediated (T cell) and humoral (B cell) immunity.
X-Linked Recessive: Mutation in IL-2RG (common γ \gamma γ -chain subunit of IL-2, IL-4, IL-7, IL-9, and IL-15 receptors), impairing T-cell and NK-cell development.
Autosomal Recessive: Adenosine Deaminase (ADA) deficiency , leading to accumulation of toxic dATP, which inhibits ribonucleotide reductase and destroys lymphocytes.
Presentation: Early infant failure to thrive, persistent candidiasis (thrush), chronic diarrhea, and fatal opportunistic infections ( Pneumocystis jirovecii , CMV). Chest X-ray reveals absent thymic shadow . Curative treatment requires hematopoietic stem cell transplantation (HSCT).
DiGeorge Syndrome (22q11.2 Deletion): Microdeletion of chromosome 22q11.2 causes developmental failure of the 3rd and 4th pharyngeal pouches . Classic triad:
Thymic Aplasia: Absent T-cell-mediated immunity (recurrent viral, fungal, and intracellular bacterial infections).
Parathyroid Aplasia: Failure of parathyroid development causing severe hypocalcemia and neonatal tetany/seizures.
Conotruncal Cardiac Defects: Tetralogy of Fallot, Truncus Arteriosus, interrupted aortic arch. (Mnemonic CATCH-22 ).
Wiskott-Aldrich Syndrome (WAS): X-linked mutation in the WAS gene , impairing actin cytoskeleton reorganization required for T-cell signaling and platelet formation. Classic Triad ( WATER ): W iskott- A ldrich, T hrombocytopenia (with small microthrombocytes), E czema, and R ecurrent infections. Immunoglobulin profile: elevated IgE and IgA, normal/low IgG, and low IgM.
Hyper-IgM Syndrome: X-linked recessive defect in CD40L (CD154) on CD4+ T helper cells. T cells cannot signal B-cell CD40 to induce class switch recombination or somatic hypermutation. Laboratory findings reveal elevated or normal IgM with severely low/absent IgG, IgA, and IgE . Patients suffer recurrent pyogenic sinopulmonary infections and opportunistic infections ( Pneumocystis jirovecii , Cryptosporidium ).
Transplantation Immunology
Transplant rejection is driven by host recognition of non-self HLA antigens on the donor organ. [Transplant Rejection Spectrum]
- Hyperacute: Minutes to Hours | Pre-existing recipient antibodies | Thrombosis & Graft Ischemia
- Acute: Weeks to Months | Recipient CD8+ T cells or DSAs | Vasculitis, Tubulitis, C4d+
- Chronic: Months to Years | CD4+ T-cell cytokines & Antibodies| Arteriosclerosis & Fibrosis
- GVHD: Post-Bone Marrow | Donor T cells attack recipient | Skin, Liver, GI Tract Damage
- Rejection Types
Hyperacute Rejection (Minutes to Hours): Occurs immediately upon vascular reperfusion. Driven by pre-existing recipient antibodies against donor ABO or HLA antigens (from prior blood transfusions, pregnancy, or organ transplants). Antibodies bind graft endothelium → \rightarrow → activate classical complement → \rightarrow → widespread endothelial thrombosis, fibrinoid necrosis, and ischemic organ death ("cyanotic graft"). Prevented by pre-transplant ABO matching and lymphocytotoxic crossmatching.
Acute Rejection (Weeks to Months):
Cell-Mediated: Recipient CD8+ CTLs directly attack donor parenchymal cells, and CD4+ Th1 cells induce delayed hypersensitivity. Histology shows dense interstitial lymphocytic infiltrates, endothelialitis, and renal tubulitis.
Humoral (Antibody-Mediated): Recipient develops de novo donor-specific antibodies (DSAs) against donor HLA, activating complement. Histology shows neutrophil capillaritis and C4d deposition in peritubular capillaries. Reversible with high-dose corticosteroids or immunosuppressants.
Chronic Rejection (Months to Years): Combined cellular and humoral immune response. CD4+ T cells secrete cytokines that stimulate vascular smooth muscle proliferation and intimal thickening. Results in progressive arteriosclerosis , vessel occlusion, interstitial fibrosis, and parenchymal atrophy. Manifests as chronic allograft nephropathy (kidney), accelerated graft coronary artery disease (heart), and bronchiolitis obliterans (lung). Irreversible.
Graft-versus-Host Disease (GVHD): Occurs following allogeneic bone marrow or hematopoietic stem cell transplantation. Immunocompetent donor T cells recognize recipient host HLA antigens as foreign and launch a systemic attack. Classic target triad: Skin (maculopapular rash, desquamation), Liver (jaundice, hyperbilirubinemia, hepatomegaly), and Gastrointestinal Tract (profuse watery or bloody diarrhea, abdominal pain).
Vaccine Types and Immunologic Mechanisms
Vaccines induce active immunity by exposing the immune system to non-pathogenic antigens, establishing long-lived memory T and B cells.
Vaccine Category Key Examples Immunologic Mechanism Clinical Advantages & Disadvantages
Live Attenuated MMR, Varicella, Sabin oral polio (OPV), Yellow fever, Rotavirus, BCG, Intranasal Flu Organism replicates intracellularly; presents on MHC Class I and II ; activates CD8+ CTLs, CD4+ Th cells, and IgA/IgG antibodies Advantage: Strong, durable humoral & cell-mediated memory; often single-dose.; Disadvantage: Risk of reversion to virulence; contraindicated in pregnancy & severe immunodeficiency .
Inactivated / Killed Rabies, Hepatitis A, Salk polio (IPV), Injected Influenza Pathogen killed by heat/formalin; presents on MHC Class II ; drives CD4+ Th and IgG humoral responses Advantage: Safe in immunocompromised/pregnant patients; no reversion.; Disadvantage: Weaker memory; no CD8+ response; requires booster doses.
Subunit / Toxoid / Conjugate Tetanus & Diphtheria toxoids, HBV (HBsAg), HPV, Hib conjugate, PCV13 conjugate Purified protein, toxoid, or capsular polysaccharide antigen presented on MHC II Advantage: High safety profile, targeted immunity.; Disadvantage: Polysaccharides alone do not activate T cells (poor in infants <2 yrs); requires protein conjugation (e.g., Hib).
Conjugate Vaccine Immunology
Pure capsular polysaccharides (e.g., Haemophilus influenzae type b or Streptococcus pneumoniae ) are T-cell-independent antigens . They cross-link B-cell receptors but cannot be presented on MHC Class II, producing only weak IgM responses without memory or affinity maturation—a major limitation in infants under 2 years old. Conjugation links the polysaccharide antigen to a strong protein carrier (e.g., diphtheria toxoid). B cells internalize the conjugate, process the protein carrier, and present carrier peptides on MHC Class II to CD4+ T cells. T-cell help stimulates B-cell class switching to IgG , producing high-affinity antibodies and long-lived memory.